✦ LIBER ✦
Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): Early results of RTOG 0132/ACRIN 6665
✍ Scribed by Burton L. Eisenberg; Jonathan Harris; Charles D. Blanke; George D. Demetri; Michael C. Heinrich; James C. Watson; John P. Hoffman; Scott Okuno; John M. Kane; Margaret von Mehren
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 123 KB
- Volume
- 99
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.